IFC & Insurance Marketing’s Merck MRK Stock Holding History

IFC & Insurance Marketing’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-293	Closed	-$31K	–	459
2025 Q4	$31K	Buy	+293	New	+$27.5K	0.03%	231

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

IFC & Insurance Marketing's MRK Position: Q1 2026 in Review

IFC & Insurance Marketing sold out of Merck (MRK) in Q1 2026, closing a stake of 293 shares — an estimated $31K sold.

IFC & Insurance Marketing first reported a position in MRK in Q4 2025 and held it in 1 quarter. The position peaked at $31K in Q4 2025. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

IFC & Insurance Marketing reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
IFC & Insurance Marketing sold 293 Merck shares in Q1 2026, an estimated $31K.
IFC & Insurance Marketing first reported a position in Merck in Q4 2025 and held it in 1 quarter.
IFC & Insurance Marketing's Merck position peaked at $31K in Q4 2025.
3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on IFC & Insurance Marketing's 13F filing for Q1 2026, filed 17 Apr 2026.